Proteomics reveals the protective mechanism of salvianolate injection on early hyperacute myocardial infarction
10.16438/j.0513-4870.2022-1141
- VernacularTitle:基于蛋白质组学探讨注射用丹参多酚酸盐对心梗超急性期保护机制研究
- Author:
Ao-ao WANG
1
;
Lei LI
1
;
Zi-yan WANG
1
;
Ce CAO
1
;
Ying LI
1
;
Zi-xin LIU
1
;
Ling-mei LI
1
;
Yue SHI
1
;
Yan-lei MA
1
;
Ying-hong PAN
2
;
Jian-xun LIU
1
Author Information
1. Beijing Key Laboratory of Chinese Materia Pharmacology, National Clinical Research Center for Cardiovascular Diseases of Traditional Chinese Medicine, Institute of Basic Medical Sciences of Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing 100091, China
2. Institute of Crop Science, Chinese Academy of Agricultural Sciences, Beijing 100081, China
- Publication Type:Research Article
- Keywords:
myocardial infarction;
early hyperacute injury phase;
salvianolate injection;
heat shock protein B6;
proteomics;
traditional Chinese medicine injection
- From:
Acta Pharmaceutica Sinica
2023;58(5):1188-1195
- CountryChina
- Language:Chinese
-
Abstract:
The hyperacute stage of myocardial infarction refers to a period of time within 30 minutes after the occurrence of myocardial infarction, when the symptoms are not obvious and the diagnosis is difficult, and the related pathophysiological mechanism has received less attention. In this study, proteomics was used to investigate the pathological changes in the early hyperacute phase of myocardial infarction, aiming to provide experimental evidence for pathological mechanism of myocardial infarction hyperacute stage. Meanwhile, the intervention effect and related mechanism of salvianolate injection were discussed based on heat shock protein B6 (HSPB6), aiming to benefit the clinical rational use of salvianolate injection. The protein expression changes before and after myocardial infarction model establishment were detected by label-free proteomics via mass spectrometry and analyzed by bioinformatics method. Then the binding effect of salvianolate injection on the commonly differential protein HSPB6 was evaluated by molecular docking technology, which was finally verified by animal experiments. All animal experimental protocols were approved by the Ethics Committee of Xiyuan Hosptial (2022XLC041). The results of this study showed that a total of 2 166 proteins were quantified by lable-free proteomics, of which 194 shared differential proteins were involved in myocardial injury and body regulation in the hyperacute phase of myocardial infarction, mainly involving molecular functions such as protein homodimerization activity, oxygen binding and transport, and serine endopeptidase inhibitor activity. Among them, HSPB6 protein is involved in the regulation of myocardial function. Molecular docking results indicated that magnesium salvianolate acetate, which is the main component of salvianolate injection, had the lowest binding energy with HSPB6 protein: -14.53 kcal·mol-1. Animal experiments showed that compared with the Sham group, the model group had significantly lower ejection fraction (EF) and fractional shortening (FS) (P < 0.001), cardiac blood perfusion decreased significantly (P < 0.001). There were obvious pathological changes such as myocardial fiber disorder, cardiomyocyte edema and interstitial small blood vessel congestion; the injury of cardiac function of rats in the administration group was attenuated, and the FS of rats in the low-dose group was significantly improved (P < 0.05), the pathological injury of myocardial tissue was markedly mitigated, and the expression of HSPB6 protein was up-regulated to varying degrees (P < 0.01, P < 0.001). In conclusion, salvianolate injection could be able to improve the cardiac function and pathological morphology of rats in the early hyperacute stage of myocardial infarction, and its mechanism may be related to the promotion of expression of HSPB6.
